Published in Br J Pharmacol on December 01, 1990
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol (1993) 4.68
Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A (1990) 4.49
Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A (1994) 1.83
Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med (2008) 1.61
L-arginine in low concentration improves rat intestinal water and sodium absorption from oral rehydration solutions. Gut (1997) 1.54
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology (2004) 1.54
The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol (1993) 1.51
Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A (1995) 1.35
Endogenous nitric oxide and sensory neuropeptides interact in the modulation of the rat gastric microcirculation. Br J Pharmacol (1992) 1.17
Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol (1995) 1.16
The emerging multifaceted roles of nitric oxide. Ann Surg (1995) 1.16
Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol (1994) 1.15
Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut (1998) 1.15
Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br J Pharmacol (1993) 1.14
The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol (1993) 1.10
Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors. Br J Pharmacol (1993) 1.08
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol (1995) 1.05
The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol (2008) 1.03
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med (1992) 1.01
Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol (1995) 0.98
Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo. Br J Pharmacol (1995) 0.97
Nitric oxide mediates the inhibition by interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion. Br J Pharmacol (1993) 0.96
Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr (2008) 0.92
Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol (1994) 0.90
Regional intestinal blood flow and nitric oxide synthase inhibition during sepsis in the rat. Ann Surg (1998) 0.90
Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol (1993) 0.88
Prophylactic administration of L-arginine improves the intestinal barrier function after mesenteric ischaemia. Gut (1996) 0.88
On the protective mechanisms of nitric oxide in acute pancreatitis. Gut (1998) 0.87
Pathogenesis of neonatal necrotizing enterocolitis. Pediatr Surg Int (2015) 0.86
Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation (2001) 0.86
Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol (1996) 0.86
Inducible nitric oxide synthase and guinea-pig ileitis induced by adjuvant. Mediators Inflamm (1995) 0.85
Involvement of superoxide and xanthine oxidase in neutrophil-independent rat gastric damage induced by NO donors. Br J Pharmacol (1995) 0.85
The involvement of endothelial dysfunction, nitric oxide and prostanoids in the rat gastric microcirculatory responses to endothelin-1. Br J Pharmacol (1994) 0.85
Role of nitric oxide in inflammation and tissue injury during endotoxemia and hemorrhagic shock. Environ Health Perspect (1998) 0.84
Induction of nitric oxide synthase in rat intestine and its association with tissue injury. Agents Actions (1993) 0.83
Gut in diseases: physiological elements and their clinical significance. World J Gastroenterol (2003) 0.81
The role of intrapulmonary nitric oxide generation in the development of adult respiratory distress syndrome. Surg Today (1999) 0.81
Inducible nitric oxide synthase inhibitors ameliorate hypermotility observed after T. spiralis infection in the rat. Dig Dis Sci (2003) 0.80
Hyperbaric oxygen increases plasma exudation in rat trachea: involvement of nitric oxide. Br J Pharmacol (1999) 0.79
Manipulation of nitric oxide in an animal model of acute liver injury. The impact on liver and intestinal function. Libyan J Med (2007) 0.78
Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol (1995) 0.78
Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model. Ann Surg (1998) 0.77
Fructose-1,6-biphosphate in rat intestinal preconditioning: involvement of nitric oxide. Gut (2001) 0.77
The effect of intraoperative colonic lavage with NG-nitro-L-arginine methyl ester (L-NAME) on anastomotic healing in the presence of left-sided colonic obstruction in the rat. Surg Today (2000) 0.77
Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis caused by environmental stress in the rat. Br J Pharmacol (1996) 0.76
Differential effect of nitric oxide inhibition as a function of preservation period in pancreas transplantation. Dig Dis Sci (1997) 0.76
Poster communications. Br J Pharmacol (1993) 0.75
Intensive care. Postgrad Med J (1993) 0.75
Body composition and grip strength are improved in transgenic sickle mice fed a high-protein diet. J Nutr Sci (2015) 0.75
Beneficial haemodynamic effect of indomethacin during endotoxin shock in anaesthetized pigsputative involvement of nitric oxide? Mediators Inflamm (1995) 0.75
Role of endogenous and exogenous nitric oxide on intestinal mucosa and microflora in the rat. Inflammation (1997) 0.75
The effect on the intestines of continuous release of methylene blue from a drug delivery system: an experimental study in a chick embryo gastroschisis model. Pediatr Surg Int (2004) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry (1988) 10.17
Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A (1989) 8.34
Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun (1988) 8.17
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun (1988) 7.77
Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1985) 7.36
Role of endothelium in responses of vascular smooth muscle. Circ Res (1983) 7.03
L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol (1987) 6.93
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol (1987) 4.88
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55
Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol (1982) 4.38
Superoxide radicals in feline intestinal ischemia. Gastroenterology (1981) 4.04
Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J (1989) 3.70
Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med (1980) 3.13
Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93
Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol (1987) 2.75
Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol (1989) 2.44
Phagocyte-generated oxygen metabolites and cellular injury. Lab Invest (1982) 2.43
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol (1990) 1.93
Mammalian nitrate biosynthesis: incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci U S A (1983) 1.83
The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol (1989) 1.60
Direct effects of E coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am J Pathol (1986) 1.54
Septic shock. Hemodynamics and pathogenesis. JAMA (1984) 1.25
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology (1987) 1.24
Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins (1986) 1.10
Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05
Lipopolysaccharide increases release of a nitric oxide-like factor from endothelial cells. Eur J Pharmacol (1989) 1.04
Increased intestinal formation of Paf in endotoxin-induced damage in the rat. Br J Pharmacol (1987) 1.00
Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins (1989) 0.94
Beneficial effects of prostacyclin in a rabbit endotoxin shock model. Thromb Res (1988) 0.91
Experimental endotoxemia in the rat: efficacy of prostacyclin or the prostacyclin analog iloprost. Circ Shock (1985) 0.86
Salutary effects of prostacyclin in endotoxic shock. Pharmacology (1980) 0.86
Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J (1989) 3.70
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem (1997) 3.52
Gastric mucosal blood flow during pentagastrin- and histamine-stimulated acid secretion in the rat. Br J Pharmacol (1973) 2.55
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (1980) 2.24
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology (1981) 2.13
Proceedings: Effects of prostaglandin E2 on rat gastric mucosal blood flow, as determined by 14C-aniline clearance. Br J Pharmacol (1972) 2.08
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins (1978) 1.85
The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat. Br J Pharmacol (1973) 1.79
Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature (1986) 1.73
Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins. Br J Pharmacol (1977) 1.68
Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature (1981) 1.62
The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol (1989) 1.60
The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol (1993) 1.51
Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol (1993) 1.47
Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol (1975) 1.46
Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol (1990) 1.41
Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro. Prostaglandins (1978) 1.39
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Potency and selectivity of methyl analogues of prostaglandin E2 on rat gastrointestinal function. Br J Pharmacol (1975) 1.36
Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur J Pharmacol (1976) 1.35
Nitric oxide donors increase mucus gel thickness in rat stomach. Eur J Pharmacol (1992) 1.31
Uptake and inactivation of prostaglandin E2 methyl analogues in the rat pulmonary circulation. Br J Pharmacol (1978) 1.30
Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. Eur J Pharmacol (1988) 1.28
Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions (1988) 1.27
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology (1987) 1.24
Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion. Gastroenterology (1992) 1.22
The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol (1988) 1.18
Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol (1993) 1.17
Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am J Physiol (1985) 1.17
Endogenous nitric oxide and sensory neuropeptides interact in the modulation of the rat gastric microcirculation. Br J Pharmacol (1992) 1.17
Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull (1983) 1.16
Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. Prostaglandins (1983) 1.16
Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci (1985) 1.16
Role of mucus in the repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents. Gastroenterology (1986) 1.16
Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation. Prostaglandins (1980) 1.15
Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol (1994) 1.15
Role of prostanoids in the protective actions of BW755C on the gastric mucosa. Eur J Pharmacol (1985) 1.14
Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol (1992) 1.13
Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br J Pharmacol (1993) 1.13
Effects of indomethacin on rat gastric acid secretion and mucosal blood flow. Br J Pharmacol (1973) 1.13
Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat. Br J Pharmacol (1988) 1.13
Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. Am J Physiol (1986) 1.13
Prostaglandin E2 and the stimulation of rat gastric acid secretion by dibutyryl cyclic 3',5'-AMP. Eur J Pharmacol (1974) 1.12
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol (1992) 1.11
The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol (1993) 1.10
Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins (1986) 1.10
Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor. Eur J Pharmacol (1986) 1.10
Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosa. Prostaglandins (1988) 1.08
Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol (1988) 1.07
Pharmacological modulation of bronchial anaphylaxis induced by aerosol challenge in anaesthetized guinea-pigs. Br J Pharmacol (1987) 1.07
Formation of prostacyclin and its product 6-oxo-PGF1alpha by the gastric mucosa of several species [proceedings]. J Physiol (1978) 1.06
Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology (1992) 1.05
Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets. Br J Pharmacol (1986) 1.05
Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol (1995) 1.04
Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf. Br J Pharmacol (1989) 1.04
Evaluation of the protection of rat gastric mucosa by a prostaglandin analogue using cellular enzyme marker and histologic techniques. Gastroenterology (1985) 1.03
Potential endogenous inhibitor of prostaglandin synthetase in plasma: failure to inhibit cyclo-oxygenase in platelets and the gastric mucosa. J Pharm Pharmacol (1978) 1.03
Profile of gastrointestinal damage induced by platelet-activating factor. Prostaglandins (1986) 1.03
Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. Dig Dis Sci (1985) 1.02
The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems. J Pharm Pharmacol (1978) 1.02
A study of the vascular and acid-secretory responses of the rat gastric mucosa to histamine. J Physiol (1976) 1.02
Increased intestinal formation of Paf in endotoxin-induced damage in the rat. Br J Pharmacol (1987) 1.00
Gastric vascular actions of prostanoids and the dual effect of arachidonic acid. Am J Physiol (1982) 0.99
The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine (1995) 0.98
Use of the rabbit transverse stomach-strip to identify and assay prostacyclin, PGA2, PGD2 and other prostaglandins. Eur J Pharmacol (1979) 0.98
Nitric oxide mediates the inhibition by interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion. Br J Pharmacol (1993) 0.96
Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Commun (1992) 0.96
Gastric damage following local intra-arterial administration of reactive oxygen metabolites in the rat. Br J Pharmacol (1989) 0.96
The differential response of a novel bioassay tissue, the rabbit transverse stomach-strip, to prostacyclin (PGI2) and other prostaglandins [proceedings]. Br J Pharmacol (1977) 0.96
Inhibition of gastric acid secretion by stress: a protective reflex mediated by cerebral nitric oxide. Proc Natl Acad Sci U S A (1996) 0.96
Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration. Br J Pharmacol (1986) 0.95
Hemostatic mechanisms, independent of platelet aggregation, arrest gastric mucosal bleeding. Proc Natl Acad Sci U S A (1986) 0.95
Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage. Br J Pharmacol (1988) 0.94
Morphine potentiation of ethanol-induced gastric mucosal damage in the rat. Role of local sensory afferent neurons. Gastroenterology (1990) 0.94
Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins (1989) 0.94
Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol (1995) 0.93
The inhibition of histamine release from rat peritoneal mast cells by non-steroid anti-inflammatory drugs and its reversal by calcium. Br J Pharmacol (1977) 0.93
Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors. Eur J Pharmacol (1995) 0.93
Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. Br J Pharmacol (1985) 0.93
Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology (1995) 0.92
A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man. Br J Clin Pharmacol (1984) 0.91
The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes. Prostaglandins (1984) 0.91
Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C. Gut (1992) 0.90
Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. Br J Pharmacol (1989) 0.90
Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol (1994) 0.90
Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge. J Pharmacol Exp Ther (1994) 0.90
Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse. Hepatology (1988) 0.90
Effects of acute normovolemic anemia on gastric mucosal blood flow in rats: role of nitric oxide. Gastroenterology (1992) 0.90
Antithrombotic assessment and clinical potential of prostacyclin analogues. Prog Med Chem (1984) 0.89
Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pylori. Br J Pharmacol (1998) 0.88
Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease. J R Soc Med (1994) 0.88